Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie (prior sponsor, Abbott)
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
\- Participants who were receiving Kaletra or who started Kaletra therapy during the registration period.
You may not be if
Participants with a history of hypersensitivity to any ingredient of this drug.
Participants who are undergoing treatment with any of the following drugs: pimozide, ergotamine tartrate, dihydroergotamine mesilate, ergometrine maleate, methylergometrine maleate, midazolam, triazolam, vardenafil hydrochloride hydrate, sildenafil citrate (Revatio), tadalafil (Adcirca), blonanserin, azelnidipine, rivaroxaban, voriconazole.
Clareo Health | Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection
